// App-Quantinova.ai

E007 : Etanercept (ETN) biosimilar (Benapali - SB4) switches in inflammatory arthritis patients at Wrightington Hospital

Researchers

Presenter

  • Perpetual C Uke

Principal Investigators

  • Catrina Morris

  • Sarang Chitale

  • Jose James

  • Hazel Miller

  • Easwaradhas Gladston-Chelliah

Medical Centers

  • Rheumatology Research, Whipps Cross Hospital, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

  • Ankylosing spondylitis

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Etanercept biosimilar

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved